Genetic diversity of OXA-51-like genes among multidrug-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 7, 2014, Pages 1223-1228

  Aly, M ^a   Tayeb, H T ^b   Al Johani, S M ^a,c   Alyamani, E J ^d   Aldughaishem, F ^c   Alabdulkarim, I ^a   Balkhy, H H ^a,c  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^d KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; TOBRAMYCIN; BACTERIAL DNA; BETA LACTAMASE; BETA-LACTAMASE OXA-51, ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; GENE INSERTION SEQUENCE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OXA 131 GENE; OXA 132 GENE; OXA 197 GENE; OXA 23 GENE; OXA 24 GENE; OXA 51 GENE; OXA 58 GENE; OXA 79 GENE; OXA 82 GENE; OXA 92 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ACINETOBACTER INFECTIONS; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; HOSPITAL PATIENT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PREVALENCE; SAUDI ARABIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENETIC VARIATION; GENOTYPE; HUMANS; INPATIENTS; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; SAUDI ARABIA;

EID: 84903816961     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2068-0     Document Type: Article

References (24)

1. Aly M, Balkhy HH(2012) The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries. Antimicrob Resist Infect Control 1(1):26
2. Bonomo RA, Szabo D (2006)Mechanisms ofmultidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 43(Suppl 2):S49-S56. doi:10.1086/504477 (Pubitemid 44267140)
3. Munoz-Price LS, Weinstein RA (2008) Acinetobacter infection. N Engl J Med 358(12):1271-1281. doi:10.1056/NEJMra070741
4. Brown S, Amyes S (2006) OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 57(1):1-3. doi:10.1093/jac/dki425 (Pubitemid 43057051)
5. Fouad M, Attia AS, Tawakkol WM, Hashem AM (2013) Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int J Infect Dis 17(12):e1252-e1254. doi:10.1016/j.ijid.2013.07.012
6. Hasan B, Perveen K, Olsen B, Zahra R (2014) Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J Med Microbiol 63(Pt 1):50- 55. doi:10.1099/jmm.0.063925-0
7. Alsultan AA, Hamouda A, Evans BA, Amyes SG (2009) Acinetobacter baumannii: emergence of four strains with novel bla(OXA-51-like) genes in patients with diabetes mellitus. J Chemother 21(3):290-295
8. Giannouli M, Cuccurullo S, Crivaro V, Di Popolo A, Bernardo M, Tomasone F, Amato G, Brisse S, Triassi M, Utili R, Zarrilli R (2010) Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin Microbiol 48(4): 1223-1230. doi:10.1128/jcm.02263-09
9. Clinical and Laboratory Standards Institute (CLSI) (2011) Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement. CLSI, Wayne, PA
10. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21(3):538-582. doi:10.1128/cmr.00058-07
11. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA (2006) Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50(12):4114-4123. doi:10.1128/aac.00778-06 (Pubitemid 44865156)
12. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S (2010) The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5(4):e10034. doi:10.1371/journal.pone.0010034
13. Bacila I, Jakab E, Ferencz B, Popescu O (2008) MLST method (Multilocus Sequence Typing). Bacteriol Virusol Parazitol Epidemiol 53(1):13-17
14. Culebras E,González-Romo F, Head J, Gómez M,Morales G, Picazo JJ (2010) Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: epidemiology and study of patient movements. Microb Drug Resist 16(4):309-315. doi:10.1089/mdr.2009.0113
15. Figueiredo S, Poirel L, Croize J, Recule C, Nordmann P (2009) In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAba1-mediated overexpression of the natural bla(OXA-66) oxacillinase gene. Antimicrob Agents Chemother 53(6):2657-2659. doi:10.1128/AAC.01663-08
16. Hu WS, Yao SM, Fung CP, Hsieh YP, Liu CP, Lin JF (2007) An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob Agents Chemother 51(11):3844-3852. doi:10.1128/AAC.01512-06 (Pubitemid 350057780)
17. Turton JF,Ward ME,Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL (2006) The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258(1):72-77. doi:10.1111/j.1574- 6968.2006.00195.x
18. Hamouda A, Evans BA, Towner KJ, Amyes SG (2010) Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes. J Clin Microbiol 48(7):2476-2483. doi:10.1128/jcm.02431-09
19. Evans BA, Hamouda A, Towner KJ,Amyes SG (2008) OXA-51-like beta-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin Microbiol Infect 14(3):268-275. doi:10.1111/j.1469-0691.2007.01919.x (Pubitemid 351201018)
20. Grosso F, Carvalho KR, Quinteira S, Ramos A, Carvalho-Assef APDA, Asensi MD, Peixe L (2011) OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J Antimicrob Chemother 66(1):62-65. doi:10.1093/jac/dkq406
21. Evans BA, Hamouda A, Towner KJ, Amyes SG (2010) Novel genetic context of multiple bla OXA-58 genes in Acinetobacter genospecies 3. J Antimicrob Chemother 65(8):1586-1588. doi:10.1093/jac/dkq180
22. Merkier AK, Catalano M, Ramírez MS, Quiroga C, Orman B, Ratier L, Famiglietti A, Vay C, Di Martino A, Kaufman S, Centrón D (2008) Polyclonal spread of bla(OXA-23) and bla(OXA-58) in Acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries 2(3):235-240
23. Poirel L,Marqué S, Héritier C, Segonds C, Chabanon G, Nordmann P (2005) OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 49(1):202-208. doi:10.1128/AAC.49.1.202-208.2005 (Pubitemid 40065794)
24. Chen TL, Chang WC, Kuo SC, Lee YT, Chen CP, Siu LK, Cho WL, Fung CP (2010) Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU. Antimicrob Agents Chemother 54(8):3107-3112. doi:10. 1128/AAC.00128-10